Learn the evidence-based fisetin dosage protocol for clearing senescent cells, including pulsed 2-day cycles, liposomal vs standard forms, and what to expect.
Fisetin has rapidly emerged as the most potent natural senolytic compound identified in laboratory research, yet the question most people ask first is deceptively simple: how much should I take? The answer requires understanding not just dosing numbers but the entire philosophy behind senolytic therapy, a fundamentally different approach from the daily supplement routine most of us are accustomed to. Unlike vitamin D or omega-3s, which work through steady-state blood levels maintained by consistent daily intake, senolytics operate on a "hit-and-run" principle. You need to reach a threshold concentration high enough to trigger apoptosis in senescent cells, maintain that concentration long enough to be effective, and then stop. The senescent cells die, healthy cells recover, and you repeat the cycle weeks or months later.
This pulsed approach is grounded in the biology of cellular senescence itself. Senescent cells, sometimes called zombie cells, are damaged cells that have permanently stopped dividing but refuse to die through normal programmed cell death. Instead, they accumulate in tissues and secrete a toxic cocktail of inflammatory molecules, proteases, and growth factors collectively known as the senescence-associated secretory phenotype, or SASP. This SASP damages neighboring healthy cells, recruits immune cells that create chronic inflammation, and gradually degrades tissue function. The goal of senolytic therapy is to push these dysfunctional cells past their survival threshold, forcing them into the apoptotic pathway they have been resisting.
The most widely discussed fisetin protocol in the longevity community follows a pulsed 2-day cycle:
Protocol at a Glance:
This protocol originates from preclinical research conducted at the Mayo Clinic, where Dr. James Kirkland and colleagues identified fisetin as the most effective natural senolytic in a screen of flavonoid compounds. In their landmark 2018 study published in EBioMedicine, researchers administered high-dose fisetin to aged mice and observed a significant reduction in senescent cell markers across multiple tissues. The mice showed improved physical function, reduced inflammatory markers, and extended healthspan. Critically, the effective protocol was not daily low-dose supplementation but acute high-dose treatment, reflecting the hit-and-run mechanism that defines senolytic therapy.
The human translation of this mouse research involves scaling the dose appropriately. In the mouse studies, the effective dose was approximately 100 mg/kg. Direct allometric scaling to humans suggests roughly 10-20 mg/kg, which for a 70 kg (154 lb) adult translates to approximately 700-1400 mg per day. Most practitioners and self-experimenters in the longevity community have settled on a range of 1000-2000 mg taken over 2 consecutive days, with individual variation based on body weight, tolerance, and goals. For more background on the cellular mechanisms, see our Fisetin intervention page (Moderate evidence). For a head-to-head comparison with quercetin, see Fisetin vs. Quercetin: Which Senolytic Wins?.
The 2-day protocol is not arbitrary. Senolytic efficacy depends on maintaining drug concentrations above the apoptotic threshold for long enough to overcome the pro-survival signaling that keeps senescent cells alive. A single large dose might achieve peak levels but may not sustain them for sufficient duration. Two consecutive days of high-dose treatment provides a more sustained assault on the survival pathways that senescent cells rely on, particularly the BCL-2 family of anti-apoptotic proteins and the PI3K/AKT signaling network.
Think of it like this: senescent cells have built elaborate defenses against death. A single strike might wound them but allow recovery. Two days of sustained pressure overwhelms their defenses and pushes them past the point of no return. After those 2 days, you stop completely. The fisetin clears your system, healthy cells recover from any transient stress, and over the following weeks your immune system cleans up the debris from the eliminated senescent cells.
One of the biggest challenges with fisetin supplementation is bioavailability. Standard fisetin has notoriously poor oral absorption due to its low water solubility and extensive first-pass metabolism in the gut and liver. Studies suggest that only a small fraction of orally ingested fisetin reaches systemic circulation in its active form.
| Feature | Standard Fisetin | Liposomal Fisetin |
| Bioavailability | Low (estimated 5-10%) | Significantly enhanced (estimated 15-25x improvement) |
| Dose needed | 1500-2000 mg per day | 500-1000 mg per day (potentially equivalent) |
| Cost per cycle | $15-30 | $25-50 |
| Stomach tolerance | May cause mild GI upset at high doses | Generally better tolerated |
| Research basis | Direct translation from mouse studies | Based on liposomal delivery science |
Liposomal fisetin formulations encapsulate the fisetin molecule within phospholipid vesicles that protect it from degradation in the gut and enhance cellular uptake. While head-to-head clinical trials comparing liposomal to standard fisetin do not yet exist, the pharmacokinetic advantages of liposomal delivery are well established for similar flavonoid compounds.
If you opt for standard fisetin supplements, taking them with a fat-containing meal is essential. Fisetin is lipophilic, meaning it dissolves in fat rather than water. A meal containing healthy fats such as olive oil, avocado, nuts, or eggs creates micelles in the gut that dramatically improve absorption. Taking fisetin on an empty stomach wastes a significant portion of the dose.
The optimal frequency for fisetin senolytic cycles remains an open question without definitive human clinical data. Two approaches have emerged in the longevity community:
Monthly Protocol (Aggressive):
Quarterly Protocol (Conservative):
Dr. James Kirkland has publicly noted that the field does not yet know the optimal dosing frequency for humans. The AFFIRM-LITE trial at the University of Minnesota is testing fisetin in human subjects, and results from this and similar trials will eventually provide better guidance. Until then, most practitioners recommend starting with the quarterly protocol and adjusting based on subjective response and, if available, biomarker tracking. For a broader overview of senolytic approaches, see our article on senescent cells and senolytics. For ranked product picks, see the Best Senolytic Supplements 2026 guide.
The experience of a fisetin senolytic cycle varies among individuals, but commonly reported observations include:
During the 2-Day Protocol:
In the Days Following:
Over Multiple Cycles:
It is important to note that these are anecdotal reports from the biohacking and longevity community, not outcomes from controlled clinical trials. Individual responses vary widely, and some people notice nothing during or after their first cycle. The absence of dramatic effects does not mean the protocol is not working, as senescent cell clearance is a process that occurs at the cellular and tissue level without necessarily producing obvious symptoms.
When selecting a fisetin supplement for senolytic use, quality matters enormously — see also the 2026 ranked senolytic supplements guide for lab-verified picks. Here is what to look for:
Third-Party Testing: Choose products that have been independently tested for purity, potency, and contaminants. Certificates of analysis (COAs) should be available from the manufacturer. Look for testing by NSF International, USP, or ConsumerLab.
Purity Standards: Fisetin should be derived from natural sources (typically Cotinus coggygria, the smoke tree) or synthesized to pharmaceutical-grade purity. Products should specify at least 98% purity.
Dosage per Capsule: For senolytic protocols requiring 1000-2000 mg, products with 500 mg per capsule minimize the number of pills needed. Some products contain only 100 mg per capsule, making high-dose protocols impractical and expensive.
Additives and Fillers: Avoid products with unnecessary fillers, artificial colors, or allergens. Simple formulations with minimal excipients are preferable.
| Product Type | Typical Dose/Cap | Capsules Needed (2-day) | Approximate Cost |
| Standard Fisetin 500mg | 500 mg | 4-8 per day | $15-30/cycle |
| Standard Fisetin 100mg | 100 mg | 10-20 per day | $20-40/cycle |
| Liposomal Fisetin 250mg | 250 mg | 2-4 per day | $25-50/cycle |
Some practitioners combine fisetin with quercetin during senolytic cycles, reasoning that the two flavonoids target slightly different anti-apoptotic pathways in senescent cells. Quercetin inhibits PI3K and serpine signaling, while fisetin acts more broadly across BCL-2 family proteins and the PI3K/AKT/mTOR axis. The combination may provide more comprehensive senolytic coverage than either compound alone. For more on quercetin, see our Quercetin intervention page (Good evidence).
A typical combination protocol might include:
For a detailed head-to-head analysis, see our fisetin vs quercetin comparison. If you are new to senolytics entirely, our senolytic protocol beginner's guide walks you through the basics step by step.
Fisetin has a favorable safety profile in the doses studied to date. As a naturally occurring flavonoid present in common foods like strawberries and apples, it has a long history of dietary exposure. However, the senolytic doses used in protocols (1000-2000 mg) are orders of magnitude higher than what you would obtain from food. At these pharmacological doses, considerations include:
Strawberries are the richest dietary source of fisetin, containing approximately 160 micrograms per gram. To reach a senolytic dose of 1500 mg, you would need to eat roughly 9-10 kg (about 20 lbs) of strawberries in a single day. While eating strawberries is certainly healthy, dietary sources cannot achieve the concentrations needed for senolytic effects. For more on dietary sources, see our guide to senolytic foods.
Currently, there is no widely available consumer test that directly measures senescent cell burden. Some advanced longevity clinics offer panels that include senescence-associated markers such as p16INK4a expression or certain SASP factors, but these are not standardized. Biological age tests (epigenetic clocks) may indirectly reflect changes over time. Most people rely on subjective markers: reduced joint stiffness, improved energy, better recovery from exercise, and reduced chronic aches.
Some people take low-dose fisetin (100-200 mg) daily for its antioxidant and anti-inflammatory properties, which is a different use case from the high-dose senolytic protocol. Daily low doses will not achieve the concentrations needed to trigger senescent cell death but may provide general health benefits through reduction of oxidative stress and NF-kB-mediated inflammation.
Fisetin has been included in clinical trials enrolling older adults, including the AFFIRM trial at the University of Minnesota which targeted adults aged 70 and older with frailty. While the full results of these trials are still emerging, the preliminary safety data has been encouraging. Older adults should start with the conservative quarterly protocol and work with a healthcare provider familiar with longevity medicine.
There is no established optimal time of day for fisetin dosing. Most practitioners recommend splitting the daily dose between two fat-containing meals, such as taking half with breakfast and half with lunch or dinner. This distributes absorption and may reduce GI discomfort compared to taking the full dose at once.
Fisetin represents one of the most promising natural senolytic compounds available today, backed by compelling preclinical research and an active clinical trial pipeline. The pulsed 2-day protocol of 1000-2000 mg, repeated monthly or quarterly, aligns with the hit-and-run mechanism that defines effective senolytic therapy. While we await definitive human clinical trial data, the safety profile of fisetin is reassuring, and the potential benefits of reducing senescent cell burden are substantial. Whether you choose standard or liposomal formulations, the key principles remain the same: high dose, short duration, adequate fat for absorption, and patient consistency across multiple cycles.